Gilad E Amiel
Overview
Explore the profile of Gilad E Amiel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
608
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Aro T, Mullerad M, Amiel G
Rambam Maimonides Med J
. 2017 Oct;
8(4).
PMID: 29059044
Although the word "robot" was coined in 1921, only close to 70 years later were robotic devices developed to assist during surgery. Urology has always been at the forefront of...
12.
Mullerad M, Aguinaga J, Aro T, Kastin A, Goldin O, Kravtsov A, et al.
Rambam Maimonides Med J
. 2017 Sep;
8(4).
PMID: 28914602
Objective: The Lumenis High-power Holmium Laser (120H) has a unique modulated pulse mode, Moses™ technology. Moses technology modulates the laser pulse to separate the water (vapor bubble), then deliver the...
13.
Javitt M, Kravtsov A, Keidar Z, Abadi S, Amiel G
Rambam Maimonides Med J
. 2017 Aug;
8(4).
PMID: 28777073
Recent developments in diagnostic imaging herald a new approach to diagnosis and management of prostate cancer. Multimodality fusion that combines anatomic with functional imaging data has surpassed either of the...
14.
Brooks M, Godoy G, Sun M, Shariat S, Amiel G, Lerner S
J Urol
. 2015 Sep;
195(2):283-9.
PMID: 26343350
Purpose: We externally validated 3 previously published nomograms to predicting recurrence, and cancer specific and overall survival following radical cystectomy and pelvic lymph node dissection for urothelial carcinoma of the...
15.
Kowalkowski M, Chandrashekar A, Amiel G, Lerner S, Wittmann D, Latini D, et al.
Sex Med
. 2014 Oct;
2(3):141-51.
PMID: 25356311
Introduction: More than 70,000 new cases of bladder cancer are diagnosed in the United States annually; with 75% being non-muscle-invasive (NMIBC). Research examining sexual dysfunction in bladder cancer survivors is...
16.
Kowalkowski M, Goltz H, Petersen N, Amiel G, Lerner S, Latini D
J Cancer Educ
. 2014 Apr;
29(4):739-45.
PMID: 24719024
Cancer survivors who continue to smoke following diagnosis are at increased risk for recurrence. Yet, smoking prevalence among survivors is similar to the general population. Adherence to cystoscopic surveillance is...
17.
Hosain G, Khan M, Amiel G, Lerner S, Latini D, Chen G
Ethn Dis
. 2012 Aug;
22(3):295-301.
PMID: 22870572
Objectives: Information on clinical characteristics, pattern of initial treatment and survival in patient with upper-tract urothelial carcinomas (UTUC) is scarce. Our study examined the racial/ethnic differences in patients diagnosed with...
18.
Ku J, Godoy G, Amiel G, Lerner S
BJU Int
. 2012 Feb;
110(5):630-6.
PMID: 22353238
What's known on the subject? and What does the study add? Although many tests for identifying patients with new or recurrent bladder cancer have been used, a reliable method has...
19.
Sonpavde G, Khan M, Svatek R, Lee R, Novara G, Tilki D, et al.
J Urol
. 2011 Feb;
185(4):1216-21.
PMID: 21334687
Purpose: Patients with pathological T3N0 stage urothelial carcinoma of the bladder show a range of outcomes after radical cystectomy. Given that nomograms have included heterogeneous groups of patients, we focused...
20.
Sonpavde G, Khan M, Svatek R, Lee R, Novara G, Tilki D, et al.
BJU Int
. 2010 Nov;
108(5):687-92.
PMID: 21087453
Objective: • To stratify risk of pathological (p) T2N0 urothelial carcinoma of the bladder after radical cystectomy (RC) based on pathological factors to facilitate the development of adjuvant therapy trials...